Efficacy from the Phase 1 Study of FID-007, a Novel Nanoparticle Paclitaxel Formulation, in Patients with Head and Neck Squamous Cell Carcinoma.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined